Company intelligence / Profile preview

Allypharma

Switzerland

Ownership: Private
Development stage: Other

Overview

Allypharma SAGL is an active Swiss-based consultancy specializing in strategic consulting for the life sciences and pharmaceutical industries. The firm focuses on facilitating international collaborations, managing complex projects, supporting business development, licensing, alliance management, product management, market access, and medical affairs. Its team comprises experienced pharma executives with decades of global experience. No clinical results are available as it does not conduct clinical trials. Active since at least 2023–2025 based on web presence.

Industry: Consulting

Partnerships

Facilitates client partnerships

Beyond the preview

Go deeper on Allypharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allypharma.

Explore the full profile